Company news

Cencora, Inc. news in 2026

Cencora, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results

November 4, 2026

Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus

November 4, 2026

Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology

October 21, 2026

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

October 2, 2026

Cencora Elects Robert E. Sanchez to Its Board of Directors

September 25, 2026

Q3 2026 Cencora Earnings Presentation

August 5, 2026

Cencora Reports Fiscal 2026 Third Quarter Results

August 5, 2026

Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

July 1, 2026

Cencora Announces Samantha Hammock as Chief Human Resources Officer

June 15, 2026

Cencora to Support U.S. Distribution of Kite’s CAR T-Cell Therapies

June 2, 2026

Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer

May 27, 2026

Cencora Announces Updated Fiscal Year 2026 Financial Outlook

May 21, 2026

Cencora Reports Fiscal 2026 Second Quarter Results

May 6, 2026

Pharmaceutical supply chain experts discuss the transition to the FDA’s new 12-digit NDC format with Drug Topics and Pharmaceutical Commerce

April 24, 2026

Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives

April 16, 2026

Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling

April 13, 2026

Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release

April 1, 2026

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business

March 23, 2026

Cencora Releases Fiscal Year 2025 Corporate Responsibility Report, Marking 10 Years of Purpose in Action

March 18, 2026

Cencora Announces Financial Leadership Transition

March 17, 2026

CDP Climate Change Disclosure

March 9, 2026

Human Rights Statement

March 5, 2026

Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics

February 27, 2026

Covetrus and MWI Animal Health to Merge

February 18, 2026

Cencora Closes $3.0 Billion Senior Notes Offering

February 13, 2026

Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

February 10, 2026

Cencora Reports Fiscal 2026 First Quarter Results

February 4, 2026

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

January 22, 2026

Cencora Elects Ellen Cooper to Its Board of Directors

January 22, 2026

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

January 6, 2026

Calls in 2026

Decks in 2026